Core Insights - The inauguration of the OneBiome laboratory in Saclay, Paris, marks a significant step for Danone in the field of science-based innovation and gut health research [1] - The laboratory will serve as a global R&D hub for Danone, focusing on gut microbiome, nutrition, and digital health, reinforcing its leadership in shaping the future of food and health [1] - Danone's CEO emphasized that the OneBiome laboratory is a milestone in the "Renewed Danone" strategy, enhancing the company's capabilities in gut microbiome research [2] Research and Development Focus - The OneBiome laboratory will leverage Danone's century-long expertise, scientific data, clinical research, and consumer insights to accelerate research on gut microbiome and its impact on overall health [1] - Advanced microbiology, artificial intelligence, and data science will be utilized to develop precise nutritional solutions, strengthening Danone's leadership in gut health and digital science [1] - The company aims to explore the potential of prebiotics, probiotics, postbiotics, and synbiotics for gut health, continuing its commitment to scientific-driven health innovation [2] Market and Consumer Insights - A survey conducted by IFOP in June 2025 revealed that half of the respondents believe their gut microbiome is unhealthy, highlighting the ongoing need for education and innovation in this field [1] - Danone is committed to empowering consumer health through gut microbiome science, offering nutrition solutions that cover the entire life cycle [2] - In China, Danone's unique digital ecosystem allows for rapid innovation and feedback, enabling the company to create valuable solutions for patients, consumers, and healthcare professionals [3]

Core Insights - Danone has officially launched the OneBiome laboratory in Saclay, Paris, marking a significant step in scientific innovation and gut health research [1] - The laboratory will serve as a global R&D hub for Danone in the fields of gut microbiome, nutrition, and digital health, reinforcing its leadership in health-driven innovation [1] - Danone's CEO emphasized that the laboratory's opening is a milestone in the "Renewed Danone" strategy, enhancing the company's capabilities in gut microbiome research [1] Group 1 - Danone is committed to empowering consumer health through gut microbiome science, offering nutrition solutions that cover the entire life cycle [1] - The company has introduced products like the Aptamil series, which contains specific prebiotics and probiotics to support healthy gut microbiomes in infants [1] - A recent clinical study named "Xuanwu" demonstrated that Danone's proprietary synbiotic combination can significantly benefit the health of the elderly by targeting gut microbiome rejuvenation [1] Group 2 - Danone's President for China, North Asia, and Oceania highlighted the importance of combining global research with local insights to deliver health value to consumers [2] - The unique digital ecosystem in China allows Danone to rapidly innovate, gather feedback, and continuously iterate on solutions for patients, consumers, and healthcare professionals [2] - The speed and scale of operations in China enable Danone to effectively serve local needs while benefiting global markets [2]